Fecal carriage rates of extended-spectrum β-lactamase-producing escherichia coli among antibiotic naive healthy human volunteers

Microbial Drug Resistance

Volumn 21, Issue 1, 2015, Pages 59-64

  Mathai, Dilip ^a   Kumar, Vasudevan Anil ^b   Paul, Breezy ^c   Sugumar, Madhan ^c   John, Kamala Russel ^c   Manoharan, Anand ^c   Kesavan, Lalitha Mukkai ^c  

^a Apollo Institute of Medical Sciences and Research   (India)

^b AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^c CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; TAZOBACTAM; TICARCILLIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE; ESCHERICHIA COLI PROTEIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FECES; FECES MICROFLORA; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MULTIDRUG RESISTANCE; MULTIPLEX POLYMERASE CHAIN REACTION; NORMAL HUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; ASYMPTOMATIC DISEASE; CELL CLONE; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE CARRIER; ENZYMOLOGY; ESCHERICHIA COLI INFECTIONS; GENETICS; HETEROZYGOTE; INDIA; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREVALENCE; RURAL POPULATION; TRANSMISSION;

ESCHERICHIA COLI;

ADULT; ANTI-BACTERIAL AGENTS; ASYMPTOMATIC DISEASES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CARRIER STATE; CLONE CELLS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE RESERVOIRS; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FECES; HUMANS; INDIA; PREVALENCE; RURAL POPULATION;

EID: 84922518946     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0031     Document Type: Article

References (36)

1. Ambler, R.P., A.F. Coulson, J.M. Frere, et al. 1991. A standard numbering scheme for the class A b-lactamases. Biochem. J. 276:269-270.
2. Arpin, C., V. Dubois, J. Maugein, J. Jullin, B. Dutilh, J.P. Brochet, G. Larribet, I. Fischer, and C. Quentin. 2005. Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting. J. Clin. Microbiol. 43:5048-5054.
3. Arpin, C., A.M. Rogues, S. Kabouche, G. Boulard, C. Quesnel, J.P. Gachie, and C. Quentin. 2000. Prospective survey of colonization and infection caused by SHV-4 producing Klebsiella pneumoniae in a neurosurgical intensive care unit. Epidemiol. Infect. 124:401-408.
4. Asensio, A., A. Oliver, P. Gonzalez-Diego, F. Baquero, J.C. Perez-Diaz, P. Ros, J. Cobo, M. Palacios, D. Lasheras, and R. Canton. 2000. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin. Infect. Dis. 30:55-60.
5. Day, K.M., S. Ali, I.A. Mirza, H.E. Sidjabat, A. Silvey, C.V. Lanyon, S.P. Cummings, S.A. Abbasi, M.W. Raza, D.L. Paterson, and J.D. Perry. 2013. Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media. Diagn. Microbiol. Infect. Dis. 75:187-191.
6. Deshpande, P., V. Vadwai, A. Shetty, R. Dalal, R. Soman, and C. Rodrigues. 2012. No NDM-1 carriage in healthy persons from Mumbai: reassuring for now. J. Antimicrob. Chemother. 67:1046-1047.
7. Ensor, V.M., M. Shahid, J.T. Evans, and P.M. Hawkey. 2006. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. J. Antimicrob. Chemother. 58:1260-1263.
8. Hussain, A., C. Ewers, N. Nandanwar, S. Guenther, S. Jadhav, L.H. Wieler, and N. Ahmed. 2012. Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-b-lactamase-producing lineage. Antimicrob. Agents Chemother. 56:6358-6365.
9. Jacoby, G.A., K.E. Walsh, D.M. Mills, V.J. Walker, H. Oh, A. Robicsek, and D.C. Hooper. 2006. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob. Agents Chemother. 50:1178-1182.
10. Jutersek, B., A. Baraniak, T. Zohar-Cretnik, A. Storman, E. Sadowy, and M. Gniadkowski. 2003. Complex endemic situation regarding extended-spectrum b-lactamaseproducing Klebsiella pneumoniae in a hospital in Slovenia. Microb. Drug Resist. 9(Suppl. 1):S25-S33.
11. Karim, A., L. Poirel, S. Nagarajan, et al. 2001. Plasmidmediated extendedspectrum b-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol. Lett. 201:237-241.
12. Kaufmann, M.E. 1998. Pulsed-field-electrophoresis. In N. Woodford and A.P. Johnson (eds.), Molecular Bacteriology: Protocols and Clinical Applications. Humana Press, Totowa, NJ, pp. 33-50.
13. Kothari, C., R. Gaind, L. Chandreshwor Singh, A. Sinha, V. Kumari, S. Arya, H. Chellani, S. Saxena, and M. Deb. 2013. Community acquisition of b-lactamase producing Enterobacteriaceae in neonatal gut. BMC Microbiol. 13:136.
14. Mammeri, H., M. Van De Loo, L. Poirel, et al. 2005. Emergence of plasmidmediated quinolone resistance in Escherichia coli in Europe. Antimicrob. Agents Chemother. 49:71-76.
15. Miro, E., B. Mirelis, F. Navarro, A. Rivera, R.J. Mesa, M.C. Roig, L. Gomez, and P. Coll. 2005. Surveillance of extended-spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain. J. Antimicrob. Chemother. 56:1152-1155. Epub 2005 Oct 21.
16. Munday, C.J., G.M. Whitehead, N.J. Todd, M. Campbell, and P.M. Hawkey. 2004. Predominance and genetic diversity of community-and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK. J. Antimicrob. Chemother. 54:628-633.
17. Muzaheed, Y., J.M. Doi, Adams-Haduch, C.T. Shivannavar, D.L. Paterson, and S.M. Gaddad. 2009. Faecal carriage of CTX-M-15-producing Klebsiella pneumoniae in patients with acute gastroenteritis. Indian J. Med. Res. 129: 599-602.
18. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement M100-S16. NCCLS, Wayne, PA, 2007.
19. Paterson, D.L., and R.A. Bonomo. 2005. Extendedspectrum b-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
20. Paterson, D.L., K.M. Hujer, A.M. Hujer, B. Yeiser, M.D. Bonomo, L.B. Rice, and R.A. Bonomo. 2003. International Klebsiella Study Group. Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV-and CTX-M-type beta-lactamases. Antimicrob. Agents Chemother. 47:3554-3560.
21. Pitout, J.D., N.D. Hanson, D.L. Church, et al. 2004. Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum b-lactamases: importance of community isolates with blaCTX-M genes. Clin. Infect. Dis. 38:1736-1741.
22. Poirel, L., T. Naas, I. Le Thomas, et al. 2001. CTX-Mtype extendedspectrum b-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob. Agents Chemother. 45:3355-3361.
23. Prats, G., B. Mirelis, E. Miro, et al. 2003. Cephalosporinresistant Escherichia coli among summer camp attendees with salmonellosis. Emerg. Infect. Dis. 9:1273-1280.
24. Rodrigues, C., U. Shukla, S. Jog, and A. Mehta. 2005. Extended-spectrum b-lactamase-producing flora in healthy persons. Emerg. Infect. Dis. 11:981-982.
25. Rodriguez-Bano, J., M.D. Navarro, L. Romero, et al. 2004. Epidemiology and clinical features of infections caused by extended-spectrum b-lactamase-producing Escherichia coli in nonhospitalized patients. J. Clin. Microbiol. 42:1089-1094.
26. Sahly, H., H. Aucken, V.J. Benedi, C. Forestier, V. Fussing, D.S. Hansen, I. Ofek, R. Podschun, D. Sirot, J.M. Tomas, D. Sandvang, and U. Ullmann. 2004. Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 48:3477-3482.
27. Sarma, J.B., and G.U. Ahmed. 2010. Prevalence and risk factors for colonisation with extended spectrum betalactamase producing enterobacteriacae vis-A-vis usage of antimicrobials. Indian J. Med. Microbiol. 28:217-220.
28. Tan, B.H., and A L. Tan. 2002. Community-acquired bacteremia with an ESBL-producing Escherichia coli strain-A case report. Int. J. Infect. Dis. 6:318-319.
29. Tangden, T., O. Cars, A. Melhus, and E. Lowdin. 2010. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob. Agents Chemother. 54:3564-3568.
30. Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
31. Toleman, M.A., D. Beidenbach, R.N. Jones, et al. 2002. Molecular characterisation of b-lactamases from Escherichia coli isolated from a multicentre trial in India: Benchmark report from the MYSTIC program. In Abstracts of the Forty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Abstract C2-1872, p. 114. American Society for Microbiology, Washington, DC.
32. Valverde, A., T.M. Coque, M.P. Sanchez-Moreno, et al. 2004. Dramatic increase in prevalence of fecal carriage of extended-spectrum blactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J. Clin. Microbiol. 42:4769-4775.
33. Vandana, K.E., G. Varghese, S. Krishna, C. Mukhopadhyay, A. Kamath, and V. Ajith. 2010. Screening at admission for carrier prevalence of multidrug-resistant organisms in resource-constrained settings: a hospital-based observational study. J. Hosp. Infect. 76:180-181.
34. Walsh, T.R., J. Weeks, D.M. Livermore, and M.A. Toleman. 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11:355-362.
35. Wang, M., D.F. Sahm, G.A. Jacoby, et al. 2004. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob. Agents Chemother. 48:1295-1299.
36. Woodford, N., M.E. Ward, M.E. Kaufmann, et al. 2004. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum b-lactamases in the UK. J. Antimicrob. Chemother. 54:735-743.